Develop Your Understanding
Listen to these pioneering discussions to hear more about the potential of psychedelic medicines.
Mind Medicine Australia Webinar Series
Our webinar series includes talks from international experts in the field of psychedelics and mental health.
Professor David Nutt (UK) presents keynote lecture ‘Psychedelic therapy: A New Paradigm For Mental Health’ at the launch of Mind Medicine Australia
Watch the video highlights of the Mind Medicine Australia 2019 Launch Event which took place on February 13th, 2019 at The University Of Melbourne
Psychedelic Therapies for Mental Illness - It's coming so you need to know about it
Australasian College of Nutritional and Environmental Medicine (ACNEM)
Tania de Jong AM and Dr Alana Roy present a webinar hosted by ACNEM on psychedelic therapies.
A novel drug trial could see ecstasy used as prescription medicine for those living with PTSD and mental illness.
60 Minutes Australia
See the results of a world-leading trial into MDMA-assisted psychotherapy.
Psychedelics Create New Communication Pathways In The Brain (Homological Scaffolds)
Watch our brains become more connected on psilocybin, and learn how psychedelics can help treat conditions such as depression, addiction, and PTSD.
The science of psilocybin and its use to relieve suffering
Roland R. Griffiths, Ph.D - Johns Hopkins
Leading psychopharmacologist Dr Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill.
Sam describes his most recent mushroom trip
Sam Harris - Neuroscientist
Sam reflects on his most recent psychedelic experience.
The future of psychedelic-assisted psychotherapy | Rick Doblin
Rick Doblin. Ph.D - Executive Director of MAPS
Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising. In this fascinating dive into the science of psychedelics, he explains how drugs like LSD, psilocybin and MDMA affect your brain — and shows how, when paired with psychotherapy, they could change the way we treat PTSD, depression, substance abuse and more.
Psychedelics: Lifting the veil
Robin Carhart-Harris Ph.D - Imperial College London
Robin has been conducting pioneering brain imaging studies of psychedelic drugs. Most recently, he has completed the first phase of a clinical trial looking at the potential of psilocybin to treat depression, and his talk looks at how these drugs can be used in treatment. After completing his PhD at the University of Bristol in 2009, Robin moved to Imperial College London, where he has worked for the last few years on the brain effects of LSD, psilocybin (magic mushrooms) and MDMA, conducting some pioneering brain imaging studies of these drugs. Most recently he has completed the first phase of a clinical trial looking at the potential of psilocybin to treat major depression.
Manifesting the Mind - Inside the Psychedelic Experience
Gabor Maté is a retired physician who, after 20 years of family practice and palliative care experience, worked for over a decade in Vancouver’s Downtown East Side with patients challenged by drug addiction and mental illness. The bestselling author of four books published in twenty-five languages, Gabor is an internationally renowned speaker highly sought after for his expertise on addiction, trauma, childhood development, and the relationship of stress and illness.
A Magic Medicine Journey: How Mind Medicine Australia is building an ecosystem for psychedelic-assisted therapies in Australia
Tania de Jong AM - Executive Director, Mind Medicine Australia
Tania de Jong presents at Psyched 2020.
Mind Medicine Australia Conversation - Trip of Compassion - Sydney
The following is a recording of a panel after our screening of Israeli documentary, Trip of Compassion in Sydney. Trip of Compassion is an acclaimed documentary on MDMA-assisted psychotherapy for the treatment of Post-Traumatic Stress Disorder (PTSD). Trip of Compassion follows several patients participating in clinical trials in Israel and is the first feature documentary to show footage from within psychedelic-assisted therapy sessions.
Our Executive Director, Tania de Jong AM, guided the panel through a great discussion of the science, ethics, policy and therapeutic potential of medicinal MDMA and psilocybin. On the panel we had Chair of Mind Medicine Australia, Peter Hunt AM, Executive Director of the Ethics centre Dr Simon Longstaff AO, The Hon. Andrew Robb AO former Federal Minister of the Liberal party, and our Education and Communication officer Melissa Warner.
Trip of Compassion
The Most Compelling Movie I’ve Seen In The Last Year
“I first watched “Trip of Compassion” about six months ago, when I was sent a link to a private video. The film had been broadcast once on Israeli television, but it wasn’t distributed or available anywhere else. This documentary affected me so deeply (and immediately) that I flew to Tel Aviv, met the filmmakers, and offered to help launch the film digitally worldwide. Everything I am doing for this film is 100% pro bono, and all proceeds go to the filmmakers.” – Tim Ferris
A Message from our Education and Communications Officer
Melissa Warner, Education and Communications Office, Mind Medicine Australia
Innovating Mind: Why Australia needs a psychedelic research program From FastSmarts: Innovator of the Year by VESKI for Melbourne Knowledge Week 2018.